Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.
Publication
, Journal Article
Alexander, KP
Published in: JAMA Cardiol
June 1, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
June 1, 2022
Volume
7
Issue
6
Start / End Page
581 / 582
Location
United States
Related Subject Headings
- Humans
- Anticoagulants
- Aged
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Alexander, K. P. (2022). Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol, 7(6), 581–582. https://doi.org/10.1001/jamacardio.2022.0477
Alexander, Karen P. “Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.” JAMA Cardiol 7, no. 6 (June 1, 2022): 581–82. https://doi.org/10.1001/jamacardio.2022.0477.
Alexander KP. Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol. 2022 Jun 1;7(6):581–2.
Alexander, Karen P. “Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone.” JAMA Cardiol, vol. 7, no. 6, June 2022, pp. 581–82. Pubmed, doi:10.1001/jamacardio.2022.0477.
Alexander KP. Meaningful Evidence for Anticoagulation in the Gray (Elder) Zone. JAMA Cardiol. 2022 Jun 1;7(6):581–582.
Published In
JAMA Cardiol
DOI
EISSN
2380-6591
Publication Date
June 1, 2022
Volume
7
Issue
6
Start / End Page
581 / 582
Location
United States
Related Subject Headings
- Humans
- Anticoagulants
- Aged
- 3201 Cardiovascular medicine and haematology